Furthermore, colon cancer patients with higher LINC01606 expression levels also had a shorter OS (p = .047, HR = 1.70) and disease‐free survival (p = .043, HR = 2.0) in GEPIA (Figure 1(E)), further indicating that LINC01606 is most likely a biomarker for colon cancer. This evidence concerns the gene LINC01606 and malignant colon neoplasm.